SCHEMBL23916420

SCHEMBL23916420

Cc1ccc(-c2ccc(N)cc2-c2nnn[nH]2)cn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 1/20 0.36
TDO2 P48775 1/20 0.36
PTGS2 P35354 3/20 0.35
PDE10A Q9Y233 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
PI4KA P42356 1/20 0.34
PIK3CG P48736 1/20 0.34
PI4KB Q9UBF8 1/20 0.34
PDE3B Q13370 4/20 0.33
PDE3A Q14432 4/20 0.33
PRMT5 O14744 1/20 0.33
WDR77 Q9BQA1 1/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
PKM P14618 1/20 0.33
MAPT P10636 1/20 0.31
GFER P55789 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23915989 0.86 PDE3B (0.31) PDE3BPDE3A
SCHEMBL23910009 0.84 MAP3K11 (0.41) TDO2PIK3CANPC1RAB9A
SCHEMBL20329236 0.84 KCNH2 (0.41) TDO2PIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL23916498 0.82 PI4KB (0.40) PTGS2PIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL20329856 0.82 PIK3CA (0.40) PIK3CDPIK3CAPIK3CBPI4KAPIK3CG
SCHEMBL23915977 0.82 KCNH2 (0.35) PDE10APIK3CAPI4KB
SCHEMBL23916028 0.82 CCNC (0.38) PIK3CBPDE3BPDE3ADYRK1ACDK2
SCHEMBL23916505 0.81 FEN1 (0.30)
SCHEMBL21135415 0.81 KCNH2 (0.41) PDE10APIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL23916415 0.81 PIK3CD (0.41) PDE10APIK3CDPIK3CAPIK3CBPI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317092-A1 TETRAZOLE CONTAINING COMPOUNDS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317092-A1 TETRAZOLE CONTAINING COMPOUNDS TSLP, IL5, TRPA1 HPGDS 198/4885TDO2 498/4885PTGS2 173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.